ACE and cancer: pos_10309 was characterised as a potential structural analogue of ramipril; therefore, the angiotensin-converting enzyme (ACE) may be its potential target, which is related to the prevention and treatment of cardiovascular diseases, and erybraedin B is a rosewood compound with potential therapeutic effects against cancer [35].